Value proposition

Digital therapeutics for cardiorenal conditions.

BodyportTM is a digital therapeutics (DTx) company on a mission: Empower every person to live free from complex chronic conditions — by delivering actionable insights gleaned from unique health signals and simple, at-home experiences.

We’re advancing the standard of care for complex chronic conditions like heart failure. By integrating a sophisticated biomarker platform into simple, easy-to-use devices, we help patients and their care teams better predict, understand, and intervene in changes to heart health — keeping people healthier and out of the hospital.

With one simple step, our platform noninvasively measures a broad spectrum of hemodynamic biomarkers to assess heart function and fluid status, giving every person at-home access to comprehensive health insights. In addition, we’re exploring the application of our platform on a range of other chronic conditions.
Learn more about us at bodyport.com